We are live on ! Find out more
CCM

Catalio Capital Management Portfolio holdings

AUM $479M
1-Year Est. Return 140.7%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+140.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$457M
AUM Growth
Cap. Flow
+$474M
Cap. Flow %
103.79%
Top 10 Hldgs %
57.34%
Holding
33
New
33
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYTX icon
26
Kyverna Therapeutics
KYTX
$484M
$2.2M 0.48%
+586,909
New +$2.81M
MGX icon
27
Metagenomi Therapeutics
MGX
$46.3M
$1.91M 0.42%
+528,993
New +$1.28M
KPTI icon
28
Karyopharm Therapeutics
KPTI
$48M
$1.58M 0.35%
+155,625
New +$1.88M
ZBIO
29
Zenas BioPharma
ZBIO
$2.05B
$1.53M 0.34%
+187,184
New +$2.92M
HYPR icon
30
Hyperfine
HYPR
$101M
$669K 0.15%
+760,035
New +$731K
GUTS icon
31
Fractyl Health
GUTS
$111M
$441K 0.1%
+214,236
New +$499K
ATAI icon
32
AtaiBeckley Inc
ATAI
$2.68B
$262K 0.06%
+196,858
New +$262K
FTH
33
Faeth Therapeutics
FTH
$629M
$144K 0.03%
+14,719
New +$148K

Similar funds

Catalio Capital Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Catalio Capital Management, which disclosed 33 positions worth $457M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is Becton Dickinson: 148,615 shares worth $33.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Catalio Capital Management's largest Q4 2024 buy was Becton Dickinson: 148,615 shares worth $33.7M.
  • Catalio Capital Management's ten largest holdings make up 57% of its $457M portfolio in Q4 2024.
  • Catalio Capital Management disclosed 33 positions in Q4 2024, its first 13F filing on record.

Based on Catalio Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.